fbpx

< Back to Thought Leadership

Phase 4 Payments: HRSA is Prepared to Send Out More Money

HRSA is prepared to send out $9B of Phase 4 PRF payments to providers this week. 75% of Phase 4 applications are processed and ready to be paid this week with over 69,000 providers receiving a payment. HRSA will send all communication through email as payments are processed and will also send communication if no payment will be issued after review of submitted applications.

This still leaves $7B of Phase 4 PRF funds to pay out and HRSA says they will continue to make payments into 2022 as applications are processed. Read the entire press release here.

Finally, we encourage you to read the terms and conditions for the Phase 4 payment and the ARP payment as new notifications to HRSA surrounding merger and acquisition activity have been added.

Phase 4 Payment Insights

Phase 4 payments are determined based on applications you submitted back in late October. You’ll need to refer to your own application to understand how your payment calculation.

Step 1: Calculate Base Payment

Approximately 75% of your payment relates to a base payment. The change in quarterly revenues and expenses from your application are multiplied by a payment percentage based on the size of your organization in the table below:

phase 4 payment calculation

Step 2: Deductions of Prior PRF Payments from Base Payments

HRSA will deduct and prior PRF payments not previously deducted in Phase 3 payments and applications.

Step 3: Calculating Bonus Payments

Approximately 25% of your payment relates to a bonus payment based on Medicare, Medicaid and CHIP claims data from January 1, 2019 through September 30, 2020. Medicaid and CHIP claims are repriced at Medicare rates and that information is used to calculate bonus payments for providers and consolidated at the TIN level.

There are additional nuances to the payment calculation if you were a new provider in 2019 or 2020 or if you were a pharmacy or DME supplier. Additionally, adjustments will be made if application data falls outside expected ranges. So while we’ve simplified the calculation above, that should only be used a guideline to validate your payment.

You can read through the entire detailed calculation and search for updates here.

Contact Us

If you have questions about the additional Phase 4 Payments, Period 2 Reporting, or Provider Relief Funds in general, please contact your local Blue & Co. advisor or one of our PRF experts below.

Michael Alessandrini, Director 

Peter Szostak, Senior Manager

Share this article

Beyond Compliance: The Strategic Value of Independent External 340B Audits

The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients.  However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]

Learn More
not-for-profit data management

From Data to Decisions: Strengthening Not-For-Profit Finance in an AI-Driven World

By Joell Grisel, CPA, Director at Blue & Co. Financial technology keeps evolving at a pace that is hard for many not-for-profits to keep up with. At Blue & Co., […]

Learn More
FY 2027 Medicare Wage Index Final PUFs: Key Deadlines and Hospital Correction Rules

FY 2027 Medicare Wage Index Final PUFs: Key Deadlines and Hospital Correction Rules

In early April 2026, a notice was sent from CMS to each MAC regarding the April 30th, 2026, release of the final FY 2027 wage index data PUFs. May 29th, […]

Learn More